Could Sponsors’ Supply Chain Policing Have Caught Alleged CRO Fraud?
The US FDA always encourages sponsors to ensure their suppliers and contractors are following the law, but agency inspectors may have been the only ones who could have discovered the data integrity problems that forced the downgrading of more than 100 generic drug applications.
You may also be interested in...
Association of inspectorates provides most detailed blueprint yet of how to assure pharmaceutical data integrity.
Data integrity issues were raised in many warning letters to active pharmaceutical ingredient manufacturers over the past four years.
The agency said its booster EUA decision was based on the immunogenicity studies that were submitted.